Baby Bunting Group Ltd (BBN)
Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026
Key indicators
| Last close | AUD 1.035 |
|---|---|
| 52-week range | 1.005 – 3.000 |
| Return, 1 month / 3 months | −3.3% / −10.4% |
| Return, 1 year / 3 years | −58.9% / −39.7% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 50.2% |
| Worst drawdown (1 year) | -65.9% |
| Average daily value traded | 0.50M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Baby Bunting Group is an Australian specialty retailer focused on products for babies, toddlers and their parents. It runs a chain of stores and an online shop offering prams, car seats, cots, nursery furniture, clothing, feeding supplies and toys. Customers are mainly expectant parents and families with young children, and the business also provides services such as car seat fitting and gift registries. The company is based in Australia.
The shares are listed on the Australian Securities Exchange in Australia under the code BBN, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Baby Bunting Group Ltd (BBN) trades on the Australian Securities Exchange in Australia. It last closed at AUD 1.035 on 20 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 1,171 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 58.9% and over the last three months it fell 10.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 20 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -32.5% | ||
| From 52-week high | -65.4% | ||
| Momentum | 28 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.4% | ||
| 6-month return | -33.2% | ||
| 12-month return, skipping the last month | -57.5% | ||
| Stability (higher is calmer) | 50 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 50.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -65.9% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 0.50M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −8.8% |
|---|---|
| 1 month | −3.3% |
| 3 months | −10.4% |
| 6 months | −33.2% |
| 1 year | −58.9% |
| 3 years | −39.7% |
| 5 years | −82.4% |
Signals
| 50-day / 200-day average | 1.132 / 1.534 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.057 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Mar 2024 | AUD 0.0180 |
| 24 Aug 2023 | AUD 0.0480 |
| 2 Mar 2023 | AUD 0.0270 |
| 25 Aug 2022 | AUD 0.0900 |
| 24 Feb 2022 | AUD 0.0660 |
| 26 Aug 2021 | AUD 0.0830 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.